DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Prostate Cancer treatment and Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019 S. 3129/H.R. 19, the Lower Costs, More Cures Act of 2019 H.R. 748, the CARES Act. H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Veterans VET
Prostate cancer clinical pathway H.R. 6092: The Veterans Prostate Cancer Treatment and Research Act
Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW SAELENS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.